Fig. 4From: Longitudinal stability of asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) studyLongitudinal stability of the bronchodilator reversible phenotype. The number of subjects (y-axis, number label) with reversible (red bars) and non-reversible (blue bars) phenotypes for response to bronchodilator, based on cut-off of change in FEV1 of 12Â % and 200Â ml, at the indicated visit (x-axis) are shown for subjects that were reversible (a) or non-reversible (b) at the screening visit, stratified by asthma severity cohortBack to article page